LLY
+4.1%🔴 Potential overreactionEli Lilly and Company · Healthcare
What happened
Why it moved
No reliable news, earnings or analyst driver was found for this move. A move this size without an obvious driver is most likely flow/positioning-driven rather than a fundamentals story.
Additional context: Viking's obesity pill advancing to Phase 3 despite competitive pressure.
Verdict — was the move justified?
🔴 Potential overreaction
A 3.0σ move well beyond the sector with no identified fundamental or news driver — the reaction appears larger than currently visible evidence justifies. Likely flow/positioning-driven.
How unusual is this move
Today’s move is among the largest 4% of LLY’s daily moves over the last 5 years — while the sector moved +1.3% and the market -0.9%.
What happened after similar moves
84 similar up moves in LLY’s 5-year history:
Median of same-direction moves within ±35% magnitude band. Past patterns don’t predict outcomes — context, not signal.
Fundamental context
Insider activity (90d): net selling $15.96M
Valuation context
Trading cheaper than 88% of its own historical valuation range.
Full fundamental analysis on PreMarketPrice
Pillar scores, financial statements, valuation history, news & more for LLY